This weekly report provides a current epidemiological update on the intensity and severity of respiratory activity in Manitoba including laboratory confirmed activity of both COVID-19 and seasonal influenza. Surveillance data include syndromic indicators, laboratory testing, associated hospitalization and mortality, and outbreaks. Updates around immunization coverage in COVID-19 and seasonal influenza are also included.
Data are reported with a one-week delay for increased data accuracy, completeness and reliability. More analyses continue to be conducted and will be added to this report as available. It is published online at approximately 10:00am every Friday.
Data extracted up to 1:00 am on January 25, 2024
Next reporting
date: February 2, 2024
|
|
|||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
|
|
||||||||||||
Important Notes
|
Figure 1. Weekly Cases of COVID-19 by Season, Manitoba, 2020 – 2024 (July through June)
Figure 2. Sex and Age Distribution of COVID-19 Cases, Manitoba, July 2, 2023 – January 20, 2024
Figure 3. Cases of COVID-19 by Health Region and Public Health Report Date, Manitoba, July 2, 2023 – January 20, 2024
Figure 4. Average Daily Testing Volume and Positivity (%) for COVID-19 by Week of Specimen Receiving Date, Manitoba, July 2, 2023 – January 20, 2024
Table 1. Fall COVID-19 Campaign Coverage (at least 1 dose) and Coverage in the Last Six Months by Age Group
Age group | Number Vaccinated | %Coverage | Number Vaccinated | %Coverage | Number Vaccinated | %Coverage |
---|---|---|---|---|---|---|
00-04 | 5530 | 6.6% | 4041 | 4.8% | 4331 | 5.1% |
05-17 | 21565 | 9.3% | 14181 | 6.1% | 14500 | 6.2% |
18-49 | 75152 | 12.4% | 50855 | 8.4% | 51312 | 8.4% |
50-64 | 73155 | 28.2% | 60293 | 23.2% | 60770 | 23.4% |
65+ | 140077 | 57.6% | 127857 | 52.6% | 129321 | 53.2% |
All | 320628 | 22.5% | 258293 | 18.1% | 262335 | 18.4% |
Figure 5. Weekly Cases of Influenza by Season, Manitoba, 2019 – 2024 (July through June)
Figure 6. Average Daily Testing Volume and Positivity (%) for Influenza by Week of Specimen Receiving Date, Manitoba, July 2, 2023 – January 20, 2024
Figure 7. Number of Positive Respiratory Virus Tests by Week of Specimen Receiving Date, Manitoba, July 2, 2023 – January 20, 2024
Note. Other respiratory viruses include adenovirus, enterovirus/rhinovirus, human coronavirus (seasonal), human metapneumovirus and human parainfluenza virus.
BackFigure 8. Weekly Respiratory Outbreaks, Manitoba, July 12, 2020 – January 20, 2024
Table 2. Coverage of Influenza Vaccinations, Manitoba
Age group | Number Vaccinated | %Coverage | Number Vaccinated | %Coverage |
---|---|---|---|---|
0-4 | 17453 | 20.7% | 13024 | 15.4% |
5-17 | 37337 | 16.1% | 29694 | 12.8% |
18-49 | 95795 | 15.8% | 84844 | 14.0% |
50-64 | 83165 | 32.0% | 75869 | 29.2% |
65+ | 146387 | 60.2% | 146023 | 60.1% |
All | 386386 | 27.1% | 353120 | 24.7% |
Note. Actual number of people vaccinated between September 1 and January 20, 2024 may be higher due to delays in reporting doses administered.
Figure 9. Weekly FluWatchers Participants and Percentage Reporting Fever and Cough, Manitoba, 2019 – January 20, 2024
Figure 10. Weekly Percentage of ILI Related Visits to Sentinel Physicians, Manitoba, 2018 – January 20, 2024
Note. The total sentinel physicians reporting during week 47 has declined and the rates should be interpreted with caution.
Figure 11. Weekly Units of Antiviral Dispensed from Pharmacies, Manitoba, 2018 – January 20, 2024
Figure 12. Weekly Respiratory Visits to Emergency Department, Manitoba, 2017 – January 20, 2024